Last reviewed · How we verify
Placebo pill imitating pentoxiphylline — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo pill imitating pentoxiphylline (Placebo pill imitating pentoxiphylline) — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. This is a placebo pill designed to mimic pentoxifylline in appearance for use as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo pill imitating pentoxiphylline TARGET | Placebo pill imitating pentoxiphylline | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo pill imitating pentoxiphylline CI watch — RSS
- Placebo pill imitating pentoxiphylline CI watch — Atom
- Placebo pill imitating pentoxiphylline CI watch — JSON
- Placebo pill imitating pentoxiphylline alone — RSS
Cite this brief
Drug Landscape (2026). Placebo pill imitating pentoxiphylline — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-pill-imitating-pentoxiphylline. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab